Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HABA LABORATORIESTSE:4925 +0.29%54 EV-to-EBIT is 3.14 as of Sep. 08, 2026, which is 56% below its 10-year median of 7.21. GuruFocus rates TSE:4925 with a GF Score™ of 54/100 and a GF Value™ of 円1,966.53 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,569 Consumer Packaged Goods companies, HABA LABORATORIES ranks better than 93.5% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
HABA LABORATORIES's Enterprise Value for the quarter that ended in Mar. 2026 was 円1,835 Mil.
HABA LABORATORIES's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円761 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HABA LABORATORIES EV-to-EBIT Related Terms
HABA LABORATORIES EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for HABA LABORATORIES's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, HABA LABORATORIES's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HABA LABORATORIES EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, HABA LABORATORIES's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where HABA LABORATORIES's EV-to-EBIT falls into.
HABA LABORATORIES's current Enterprise Value is 円2,388 Mil.
HABA LABORATORIES's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円761 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HABA LABORATORIES (TSE:4925) has a EV-to-EBIT of 3.14 as of Sep. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HABA LABORATORIES and its competitors. This is 56% below median its historical median of 7.21. According to the industry distribution chart, HABA LABORATORIES ranks #102 out of 1569 companies in the Consumer Packaged Goods industry, placing it in the top 6.5%.
Is HABA LABORATORIES's EV-to-EBIT too high?
HABA LABORATORIES's current EV-to-EBIT of 3.14 is 56% below median its 10-year median of 7.21. The Consumer Packaged Goods industry median EV-to-EBIT is 12.49. HABA LABORATORIES's value of 3.14 is 74.9% below this industry median. Based on the distribution chart, HABA LABORATORIES ranks #102 out of 1569 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, HABA LABORATORIES has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HABA LABORATORIES's EV-to-EBIT compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, HABA LABORATORIES ranks #102 out of 1569 companies for EV-to-EBIT. This places HABA LABORATORIES in the top 7% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 12.49. HABA LABORATORIES's value of 3.14 is 74.9% below this benchmark. While the company's 10-year median is 7.21 vs. the industry median of 12.49, HABA LABORATORIES has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.49, based on 1,569 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HABA LABORATORIES's current EV-to-EBIT of 3.14 is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HABA LABORATORIES and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HABA LABORATORIES's current EV-to-EBIT is 3.14, which is 56% below median its own 10-year median of 7.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HABA LABORATORIES stock overvalued right now?
Based on GuruFocus' analysis, HABA LABORATORIES (TSE:4925) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,966.53, compared to a current price of 円1,744.00 — trading 11.3% below its estimated fair value. The current EV-to-EBIT is 3.14, which is 56% below median its 10-year median of 7.21 and 74.9% below the Consumer Packaged Goods industry median of 12.49. HABA LABORATORIES's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For HABA LABORATORIES (TSE:4925), the current EV-to-EBIT is 3.14 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HABA LABORATORIES (TSE:4925) Overvalued in 2026?
Based on GuruFocus' analysis, HABA LABORATORIES stock appears to be undervalued.
The current stock price of 円1,744.00 is trading 11.3% below its estimated GF Value™ of 円1,966.53.
GuruFocus considers HABA LABORATORIES to be Modestly Undervalued.
Key valuation signals for TSE:4925:
EV-to-EBIT: 3.14 (56% below median its 10-year median of 7.21)
GF Value™: 円1,966.53 vs. price of 円1,744.00 (11.3% below fair value)
Industry Position: 74.9% below the Consumer Packaged Goods median (#102 of 1569)
No single metric tells the full story. See the TSE:4925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HABA LABORATORIES Inc along with its subsidiaries develops, manufactures and distributes natural cosmetics, quasi-drugs and nutritional supplements. The company sells its products through shops, delivery centers, mail order, and the Internet.
54GF Score
Get the complete analysis for TSE:4925
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4925 has been successfully added to your 
